Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/2003
03/19/2003CN1403140A Medicine for treating acute and chronic hepatitis B
03/19/2003CN1403136A Sore-eliminating medicine powder and its prepn and usage
03/19/2003CN1403134A Prepn of medicine for treating hepatosis
03/19/2003CN1403122A Constipation treating medicine and its prepn
03/19/2003CN1403115A Gastrointestinal disease treating Chinese medicine wine and its prepn and application
03/19/2003CN1403112A Medicine for treating kidney deficiency
03/19/2003CN1403105A Prepn of Chinese medicine granule for treating diseases of digestive system
03/19/2003CN1403104A Recipe of gastropathy treating Chinese herbal medicine
03/19/2003CN1403099A Chinese medicine prepn for treating hepatosis and its prepn process
03/19/2003CN1403092A Nutritive medicine for remitting or treating pregnant woman's vomiting
03/19/2003CN1403091A Prepn of ulcer-resisting chitosan zinc compound
03/19/2003CN1403088A Medicine composition containing polydatin or its salt and its use in preparing medicine
03/19/2003CN1403073A Oral cavity disinfectant liquor
03/19/2003CN1103373C Human serum albumin reformed gene, expression vector and its host
03/19/2003CN1103369C Bacillus preparation and its preparing process and use
03/19/2003CN1103225C Plaster for treating osteophytosis
03/19/2003CN1103223C Chinese herbal medicine preparation for treating cholecystitis
03/18/2003US6534655 Indeno[1,2-C]pyrazole derivatives for inhibiting tyrosine kinase activity
03/18/2003US6534539 Pharmaceutical composition and method for treatment of dyspepsia
03/18/2003US6534523 Racemates, diastereoisomers and optical isomers of a compound of formula (I): synthesis, compositions and methods for the treatment of hepatitis C virus (HCV) infection and intermediates
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534498 Protease inhibitors
03/18/2003US6534054 Probiotic/therapeutic uses of nonpathogenic probiobiotic microorganisms; manufacturing the formulation from the plant derived material
03/18/2003US6534053 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003WO2002021932A2 Animal feed, feed additive and therapeutic agent against intestinal inflammation
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/14/2003CA2422250A1 Animal feed, animal feed additive and medicament for intestinal inflammation
03/13/2003WO2003021273A2 Diagnosis of carcinomas
03/13/2003WO2003021262A1 Screening method
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020719A1 1,3-benzothiazinone derivatives and use thereof
03/13/2003WO2003020711A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
03/13/2003WO2003020702A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020325A2 Methods for sterilizing preparations containing albumin
03/13/2003WO2003020324A2 Methods for sterilizing preparations of digestive enzymes
03/13/2003WO2003020302A1 Hepatitis b virus proliferation inhibitor
03/13/2003WO2003020291A1 Increased solubility flavanolignan preparations
03/13/2003WO2003020282A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020275A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
03/13/2003WO2003020269A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
03/13/2003WO2003020257A2 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
03/13/2003WO2003020217A2 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003WO2003020201A2 Pre-mixes of glp-1 and basal insulin
03/13/2003WO2003020172A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
03/13/2003WO2003020037A1 Multivesicular emulsion topical delivery systems
03/13/2003WO2002100354A3 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
03/13/2003WO2002089796A3 Methods for selective immunomodulation using pimecrolimus
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002076950A3 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
03/13/2003WO2002074343A3 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body
03/13/2003WO2002072543A3 Rxr activating molecules
03/13/2003WO2002068015A3 Modular infusion device and method
03/13/2003WO2002066427A3 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/13/2003WO2002060926A3 Hepatitis c tripeptide inhibitors
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002042319A3 2-substituted estrogens as antiangiogenic agents
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002017949A3 Novel functions for dp214
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003WO2001082911A3 TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING CLIOQUINOL
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050344 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050310 Hydroxamic acid derivatives as proteinase inhibitors
03/13/2003US20030050309 A gelatinase inhibitor for modulating the activity of a dopamine, serotonin, or norepinephrine receptor or transporter
03/13/2003US20030050307 Treating certain psychiatric and neurological disorders; anxiety disorder, panic disorder, obsessive compulsive disorder, depression, social phobia and eating disorders, and psychosis
03/13/2003US20030050304 Therapeutic compounds
03/13/2003US20030050299 An intermediates for enantiomeric synthesis cermamide-like inhibitors; producing antilipemic agents
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050265 A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding transforming growth factor-beta 2
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050249 Complexes of alpha-6 integrin subunits with small peptides and methods for treating indications resulting from modulation of integrin-mediated responses by altering signal transduction
03/13/2003US20030050247 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity
03/13/2003US20030050235 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
03/13/2003US20030050229 Treatment with a 1' 2' and/or 3' nucleoside or a pharmaceutically acceptable salt or prodrug; nontoxic
03/13/2003US20030049815 Recombinant bacterial phytases and uses thereof
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049337 Using eucalyptus plant extract
1 ... 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 ... 1258